693 related articles for article (PubMed ID: 32993785)
1. Sunitinib facilitates metastatic breast cancer spreading by inducing endothelial cell senescence.
Wang D; Xiao F; Feng Z; Li M; Kong L; Huang L; Wei Y; Li H; Liu F; Zhang H; Zhang W
Breast Cancer Res; 2020 Sep; 22(1):103. PubMed ID: 32993785
[TBL] [Abstract][Full Text] [Related]
2. Enhanced efficacy of sitravatinib in metastatic models of antiangiogenic therapy resistance.
Dolan M; Mastri M; Tracz A; Christensen JG; Chatta G; Ebos JML
PLoS One; 2019; 14(8):e0220101. PubMed ID: 31369645
[TBL] [Abstract][Full Text] [Related]
3. Disturbed flow promotes endothelial senescence via a p53-dependent pathway.
Warboys CM; de Luca A; Amini N; Luong L; Duckles H; Hsiao S; White A; Biswas S; Khamis R; Chong CK; Cheung WM; Sherwin SJ; Bennett MR; Gil J; Mason JC; Haskard DO; Evans PC
Arterioscler Thromb Vasc Biol; 2014 May; 34(5):985-95. PubMed ID: 24651677
[TBL] [Abstract][Full Text] [Related]
4. Apelin inhibition prevents resistance and metastasis associated with anti-angiogenic therapy.
Uribesalgo I; Hoffmann D; Zhang Y; Kavirayani A; Lazovic J; Berta J; Novatchkova M; Pai TP; Wimmer RA; László V; Schramek D; Karim R; Tortola L; Deswal S; Haas L; Zuber J; Szűcs M; Kuba K; Dome B; Cao Y; Haubner BJ; Penninger JM
EMBO Mol Med; 2019 Aug; 11(8):e9266. PubMed ID: 31267692
[TBL] [Abstract][Full Text] [Related]
5. CXCL17-derived CD11b
Hsu YL; Yen MC; Chang WA; Tsai PH; Pan YC; Liao SH; Kuo PL
Breast Cancer Res; 2019 Feb; 21(1):23. PubMed ID: 30755260
[TBL] [Abstract][Full Text] [Related]
6. Breast cancer cells promote a notch-dependent mesenchymal phenotype in endothelial cells participating to a pro-tumoral niche.
Ghiabi P; Jiang J; Pasquier J; Maleki M; Abu-Kaoud N; Halabi N; Guerrouahen BS; Rafii S; Rafii A
J Transl Med; 2015 Jan; 13():27. PubMed ID: 25623554
[TBL] [Abstract][Full Text] [Related]
7. Effects of VEGFR1
Meng D; Meng M; Luo A; Jing X; Wang G; Huang S; Luo M; Shao S; Zhao X; Liu R
J Cancer Res Clin Oncol; 2019 Feb; 145(2):411-427. PubMed ID: 30483898
[TBL] [Abstract][Full Text] [Related]
8. Human embryonic stem cell-derived endothelial cells as cellular delivery vehicles for treatment of metastatic breast cancer.
Su W; Wang L; Zhou M; Liu Z; Hu S; Tong L; Liu Y; Fan Y; Kong D; Zheng Y; Han Z; Wu JC; Xiang R; Li Z
Cell Transplant; 2013; 22(11):2079-90. PubMed ID: 23067802
[TBL] [Abstract][Full Text] [Related]
9. Inactivation of endothelial cell phosphoinositide 3-kinase β inhibits tumor angiogenesis and tumor growth.
Azad AK; Zhabyeyev P; Vanhaesebroeck B; Eitzen G; Oudit GY; Moore RB; Murray AG
Oncogene; 2020 Oct; 39(41):6480-6492. PubMed ID: 32879446
[TBL] [Abstract][Full Text] [Related]
10. Sunitinib effects on the radiation response of endothelial and breast tumor cells.
El Kaffas A; Al-Mahrouki A; Tran WT; Giles A; Czarnota GJ
Microvasc Res; 2014 Mar; 92():1-9. PubMed ID: 24215790
[TBL] [Abstract][Full Text] [Related]
11. Aspirin Affects Tumor Angiogenesis and Sensitizes Human Glioblastoma Endothelial Cells to Temozolomide, Bevacizumab, and Sunitinib, Impairing Vascular Endothelial Growth Factor-Related Signaling.
Navone SE; Guarnaccia L; Cordiglieri C; Crisà FM; Caroli M; Locatelli M; Schisano L; Rampini P; Miozzo M; La Verde N; Riboni L; Campanella R; Marfia G
World Neurosurg; 2018 Dec; 120():e380-e391. PubMed ID: 30144594
[TBL] [Abstract][Full Text] [Related]
12. Endothelial Notch1 Activity Facilitates Metastasis.
Wieland E; Rodriguez-Vita J; Liebler SS; Mogler C; Moll I; Herberich SE; Espinet E; Herpel E; Menuchin A; Chang-Claude J; Hoffmeister M; Gebhardt C; Brenner H; Trumpp A; Siebel CW; Hecker M; Utikal J; Sprinzak D; Fischer A
Cancer Cell; 2017 Mar; 31(3):355-367. PubMed ID: 28238683
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor plays a critical role in the formation of the pre-metastatic niche via prostaglandin E2.
Liu S; Jiang M; Zhao Q; Li S; Peng Y; Zhang P; Han M
Oncol Rep; 2014 Dec; 32(6):2477-84. PubMed ID: 25333935
[TBL] [Abstract][Full Text] [Related]
14. Nitric oxide deficiency and endothelial-mesenchymal transition of pulmonary endothelium in the progression of 4T1 metastatic breast cancer in mice.
Smeda M; Kieronska A; Adamski MG; Proniewski B; Sternak M; Mohaissen T; Przyborowski K; Derszniak K; Kaczor D; Stojak M; Buczek E; Jasztal A; Wietrzyk J; Chlopicki S
Breast Cancer Res; 2018 Aug; 20(1):86. PubMed ID: 30075800
[TBL] [Abstract][Full Text] [Related]
15. Lipopolysaccharide induces inflammation and facilitates lung metastasis in a breast cancer model via the prostaglandin E2-EP2 pathway.
Li S; Xu X; Jiang M; Bi Y; Xu J; Han M
Mol Med Rep; 2015 Jun; 11(6):4454-62. PubMed ID: 25625500
[TBL] [Abstract][Full Text] [Related]
16. iPSC-Derived Hereditary Breast Cancer Model Reveals the
Portier L; Desterke C; Chaker D; Oudrhiri N; Asgarova A; Dkhissi F; Turhan AG; Bennaceur-Griscelli A; Griscelli F
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33513753
[TBL] [Abstract][Full Text] [Related]
17. Effects of vascular-endothelial protein tyrosine phosphatase inhibition on breast cancer vasculature and metastatic progression.
Goel S; Gupta N; Walcott BP; Snuderl M; Kesler CT; Kirkpatrick ND; Heishi T; Huang Y; Martin JD; Ager E; Samuel R; Wang S; Yazbek J; Vakoc BJ; Peterson RT; Padera TP; Duda DG; Fukumura D; Jain RK
J Natl Cancer Inst; 2013 Aug; 105(16):1188-201. PubMed ID: 23899555
[TBL] [Abstract][Full Text] [Related]
18. [Vascular endothelial growth factor secreted by breast cancer cells plays a critical role in the formation of pre-metastatic niche in the mouse lung].
Li R; Yuan B; Zhang Y; Dai J; Zhang P; Fang F; Han M
Zhonghua Zhong Liu Za Zhi; 2016 Jan; 38(1):17-22. PubMed ID: 26796801
[TBL] [Abstract][Full Text] [Related]
19. An immune-humanized patient-derived xenograft model of estrogen-independent, hormone receptor positive metastatic breast cancer.
Scherer SD; Riggio AI; Haroun F; DeRose YS; Ekiz HA; Fujita M; Toner J; Zhao L; Li Z; Oesterreich S; Samatar AA; Welm AL
Breast Cancer Res; 2021 Oct; 23(1):100. PubMed ID: 34717714
[TBL] [Abstract][Full Text] [Related]
20. AEE788: a dual family epidermal growth factor receptor/ErbB2 and vascular endothelial growth factor receptor tyrosine kinase inhibitor with antitumor and antiangiogenic activity.
Traxler P; Allegrini PR; Brandt R; Brueggen J; Cozens R; Fabbro D; Grosios K; Lane HA; McSheehy P; Mestan J; Meyer T; Tang C; Wartmann M; Wood J; Caravatti G
Cancer Res; 2004 Jul; 64(14):4931-41. PubMed ID: 15256466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
